• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Kythera Biopharmaceuticals

edit

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.

KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.

Milestones

edit

• 
  Kythera Biopharmaceuticals received $30M in Series C funding. (5/19/08)
  Posted 6/3/09 at 1:15am
• 
  Kythera Biopharmaceuticals added Deepak Chadha as Vice President, Regulatory Affairs.
  Posted 6/3/09 at 1:15am
• 
  Kythera Biopharmaceuticals added Keith Leonard as President and CEO.
  Posted 6/3/09 at 1:15am
• 
  Kythera Biopharmaceuticals added John Smither as CFO.
  Posted 6/3/09 at 1:15am

Videos

Screenshots

edit

Above: Homepage
Uploaded: 6/3/09

Sources

1. Capital Funding Report [edit]